The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
CYR61 (CNN1), a member of the cysteine rich 61/connective tissue growth factor/nephroblastoma overexpressed (CYR61/CTFG/NOV) family of growth regulators (CNN), is a pro-angiogenic factor that mediates diverse roles in development, cell proliferation, and tumorigenesis. We have recently shown that CYR61 is overexpressed in invasive and metastatic human breast cancer cells. Accordingly, elevated levels of CYR61 in breast cancer are associated with more advanced disease. Unfortunately, the exact mechanisms by which CYR61 promotes an aggressive breast cancer phenotype are still largely unknown. This review examines the functional role of CYR61 in breast cancer disease, presenting evidence that CYR61 signaling may play a major role in estrogen- as well as growth factor-dependent breast cancer progression. We also emphasize the functional significance of the molecular connection of CYR61 and its integrin receptor alpha(v)beta(3) enhancing breast cancer aggressiveness. Moreover, we describe experimental evidence that establishes a novel role for CYR61 determining the protection of human breast cancer cells against chemotherapy-induced apoptosis through its interactions with the integrin receptor alpha(v)beta(3). All these findings delineate a new noteworthy function of a CYR61/alpha(v)beta(3) autocrine-paracrine signaling pathway within both angiogenesis and breast cancer progression, which would allow a dual anti-angiogenic and anti-tumor benefit with a single drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lau, L. F., & Nathans, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1182 · Cited by 856
Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells.
Lau, L. F., & Nathans, D. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04057.x · Cited by 567 · cited 4×
“…minutes after stimulation by serum, epidermal growth factor, basic fibroblastic growth factor (bFGF), platelet-derived growth factor, transforming growth factor-β, and 12-Otetradecanoylphorbol 13-acetate (TPA) (Lau & Nathans 1985, 1987, Nathans et al. 1988, O’Brien et al. 1990, Tsai et al. 2002b).”
BackgroundInfluentialBabic, A. M., Kireeva, M. L., Kolesnikova, T. V., & Lau, L. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6355 · Cited by 495 · cited 2×
“…fibroblasts and endothelial cells, stimulates chemotaxis of fibroblasts and endothelial cells, and increases chondrogenesis in mesenchymal cells (O’Brien & Lau 1992, Frazier et al. 1996, Kireeva et al. 1996, 1997, 1998, Wong et al. 1997, Babic et al. 1998, Kolesnikova & Lau 1998, Chen et al. 2001).”
BackgroundKireeva, M. L., Mo, F.-E., Yang, G. P., & Lau, L. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1326 · Cited by 341 · cited 2×
“The integrin αvβ3 expression is based on results from Kireeva et al. (1996), and our preliminary data.”
BackgroundExpression of cyr61, a growth factor-inducible immediate-early gene.
O'Brien, T. P., Yang, G. P., Sanders, L., & Lau, L. F. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3569 · Cited by 310 · cited 2×
“…minutes after stimulation by serum, epidermal growth factor, basic fibroblastic growth factor (bFGF), platelet-derived growth factor, transforming growth factor-β, and 12-Otetradecanoylphorbol 13-acetate (TPA) (Lau & Nathans 1985, 1987, Nathans et al. 1988, O’Brien et al. 1990, Tsai et al. 2002b).”
BackgroundLeu, S.-J., Lam, S. C.-T., & Lau, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209288200 · Cited by 247 · cited 2×
“Importantly, CYR61 can also promote cell survival of angiogenic endothelial cells through interaction with integrin avβ3 (Leu et al. 2002).”
BackgroundJedsadayanmata, A., Chen, C.-C., Kireeva, M. L., Lau, L. F., & Lam, S. C.-T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24321 · Cited by 204
Kireeva, M. L., Lam, S. C.-T., & Lau, L. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.3090 · Cited by 203
Chen, N., Chen, C.-C., & Lau, L. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003040200 · Cited by 195
Cyr61 promotes breast tumorigenesis and cancer progression
Tsai, M.-S., Bogart, D. F., Castañeda, J. M., Li, P., & Lupu, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205682 · Cited by 189
Self-citationGrzeszkiewicz, T. M., Kirschling, D. J., Chen, N., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100978200 · Cited by 162 · cited 1×
“CYR61 is a novel ligand for integrins, and signaling through integrin receptors such as αvβ3, αvβ5, αIIbß3, and α6β1 may explain many, if not all, of the known diverse functions of CYR61 (Kireeva et al. 1998, Jedsadayanmata et al. 1999, Chen et al. 2000, Grzeszkiewicz et al. 2001).”
BackgroundWong, M., Kireeva, M. L., Kolesnikova, T. V., & Lau, L. F. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8766 · Cited by 155 · cited 1×
“…fibroblasts and endothelial cells, stimulates chemotaxis of fibroblasts and endothelial cells, and increases chondrogenesis in mesenchymal cells (O’Brien & Lau 1992, Frazier et al. 1996, Kireeva et al. 1996, 1997, 1998, Wong et al. 1997, Babic et al. 1998, Kolesnikova & Lau 1998, Chen et al. 2001).”
BackgroundXie, D., Miller, C. W., O'Kelly, J., Nakachi, K., Sakashita, A., Said, J. W., Gornbein, J., & Koeffler, H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009755200 · Cited by 146 · cited 10×
“Significantly, expression of CYR61 enhances neovascularization and tumor formation of human tumor cells in immunodeficient mice (Babic et al. 1998, 1999, Xie et al. 2001a, Tsai et al. 2002a).”
BackgroundMethodInfluentialThe human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p
Jay, P., Bergé-Lefranc, J. L., Marsollier, C., Méjean, C., Taviaux, S., & Berta, P. (1997) · Oncogene · doi:10.1038/sj.onc.1200986 · Cited by 67
Cited by
All in the CCN family: essential matricellular signaling modulators emerge from the bunker
Leask, A., & Abraham, D. J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03270 · Cited by 655
Functions and mechanisms of action of CCN matricellular proteins
Chen, C.-C., & Lau, L. F. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.025 · Cited by 549
“…ovarian, pancreatic, and prostate cancers, gliomas, hepatocellular carcinoma, non-small cell lung and squamous cell carcinoma, lymphoblastic leukemia, melanoma, and cartilaginous tumors (reviewed by Menendez et al., 2003;O’Kelly and Koeffler, 2005;Kleer et al., 2007;Yeger and Perbal, 2007).”
BackgroundLin, M.-T., Chang, C.-C., Chen, S.-T., Chang, H.-L., Su, J.-L., Chau, Y.-P., & Kuo, M.-L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402305200 · Cited by 194
The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts
Todorovicç, V., Chen, C.-C., Hay, N., & Lau, L. F. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504015 · Cited by 132
“…activities, Ccn1 expression in adulthood is associated with biological and pathological contexts in which angiogenesis and inflammation play important roles, such as wound healing, restenosis, atherosclerosis, and tumorigenesis (Grzeszkiewicz et al., 2002; for review see Menendez et al., 2003).”
BackgroundInfluentialChen, N., Leu, S.-J., Todorović, V., Lam, S. C.-T., & Lau, L. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406813200 · Cited by 132
Metadata
- Authors
- Menéndez, J. A., Mehmi, I., Griggs, D. W., & Lupu, R.
- Venue
- Endocrine-related cancer
- Publisher
- Bioscientifica
- Published
- 2003-06
- Volume
- 10
- Issue
- 2
- Pages
- 141-152
- ISSN
- 1351-0088 (ISSN-L)
- OpenAlex
- W2322173990
- Cited by
- 120
- References
- 14
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.